#USA #Los Angeles #Securities Fraud #SelectQuote #SLQT

SelectQuote Shareholders Offered Opportunity to Lead Fraud Lawsuit

The ongoing legal troubles of SelectQuote, Inc. (NYSE: SLQT) have opened a significant avenue for its shareholders who have suffered financial losses. As of October 8, 2025, Glancy Prongay & Murray LLP announced that investors may now take the lead in a securities fraud class action lawsuit against the company.

The lawsuit centers around allegations that between September 9, 2020, and May 1, 2025, SelectQuote engaged in deceptive practices relating to its promotion of Medicare Advantage plans. Investors are encouraged to act quickly; the deadline for potentially becoming a lead plaintiff is October 10, 2025.

The Claims Against SelectQuote

According to the legal complaint, there are several serious allegations against SelectQuote:
1. Misleading Information: The complaint asserts that the company failed to disclose vital information regarding its practices. Specifically, claimants argue that SelectQuote directed Medicare beneficiaries toward insurance plans based on financial benefits to SelectQuote, rather than the quality or suitability of those plans.
2. Lack of Objectivity: It is further alleged that SelectQuote did not provide unbiased comparisons among different Medicare Advantage insurance plans, which is crucial for beneficiaries making informed decisions about their healthcare coverage.
3. Illegal Kickbacks: Another grave accusation includes receiving illegal kickbacks. The lawsuit alleges that SelectQuote steered clients to certain insurers while limiting their options for enrolling in competitors' plans, a practice that potentially violates various regulations.
4. Regulatory Vulnerabilities: The complaint indicates that SelectQuote's tactics left it susceptible to significant regulatory and legal penalties, including violations of the False Claims Act, which protects against fraud in government programs like Medicare.
5. Falsely Assured Investors: The legal documents argue that SelectQuote's positive public statements about its business practices were misleading and lacked a sufficient reasonable basis.

The lawsuit raises concerns not only for financial investors but also for Medicare beneficiaries who may have unknowingly fallen prey to these practices.

How to Get Involved

Interested shareholders are encouraged to act promptly to ensure their voices are heard in this potential class action. Individuals who wish to learn more about participating in the lawsuit can reach out to Glancy Prongay & Murray LLP for additional information. Contact details are provided below.

Additionally, potential class members are reminded that at this stage, no action is required. Individuals can retain legal counsel if they choose, or they may opt to remain as absent members of the class action without immediate involvement.

For more information, affected investors can contact:

• - Charles Linehan, Esq.

Glancy Prongay & Murray LLP
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Email: [email protected]
Phone: 310-201-9150 (Toll-Free: 888-773-9224)

This extensive legal concern is indicative of the complexities and potential pitfalls surrounding investment in companies like SelectQuote, particularly in the healthcare and insurance sectors.

Conclusion

As the legal actions unfold, shareholders must stay informed and vigilant. The unfolding situation at SelectQuote serves as a critical reminder of the responsibilities companies have toward their investors and stakeholders, especially in industries as sensitive as healthcare. The outcomes of this case could set significant legal precedents and eventually reshape how insurance companies conduct business.